Kapstone Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.6M | Buy |
14,021
+2
| +0% | +$371 | 1.3% | 18 |
|
|
2025
Q1 | $2.94M | Sell |
14,019
-70
| -0.5% | -$14.7K | 1.66% | 12 |
|
|
2024
Q4 | $2.47M | Buy |
14,089
+43
| +0.3% | +$7.54K | 1.32% | 16 |
|
|
2024
Q3 | $2.74M | Buy |
14,046
+1
| +0% | +$195 | 1.66% | 13 |
|
|
2024
Q2 | $2.41M | Buy |
14,045
+208
| +2% | +$35.7K | 1.58% | 14 |
|
|
2024
Q1 | $2.52M | Sell |
13,837
-118
| -0.8% | -$21.5K | 1.72% | 11 |
|
|
2023
Q4 | $2.3M | Sell |
13,955
-32
| -0.2% | -$5.28K | 1.81% | 12 |
|
|
2023
Q3 | $2.08M | Buy |
13,987
+81
| +0.6% | +$12.1K | 1.88% | 11 |
|
|
2023
Q2 | $2.07M | Buy |
13,906
+85
| +0.6% | +$12.6K | 1.71% | 11 |
|
|
2023
Q1 | $2.25M | Sell |
13,821
-39
| -0.3% | -$6.35K | 2.03% | 8 |
|
|
2022
Q4 | $2.01M | Buy |
+13,860
| New | +$2.01M | 1.83% | 9 |
|